Synageva BioPharma Prices 2.75M Share Offering at $56.63/Share
Synageva BioPharma Corp. (“Synageva”) (NASDAQ: GEVA), a
biopharmaceutical company developing therapeutic products for rare
disorders, today announced the pricing of its previously announced
underwritten public offering of common stock consisting of 2.75 million
shares at $56.63 per share. In connection with this offering, Synageva
granted to the underwriters a 30-day option to purchase 412,500
additional shares of common stock. If the underwriters exercise this
option, Synageva will have offered approximately 3.16 million shares of
its common stock.
Goldman, Sachs & Co. is acting as the sole book-running manager in the
offering. Morgan Stanley & Co., Cowen and Company, and Canaccord Genuity
Inc. are acting as co-managers in the offering.